The Multicenter Cardiology Monitoring Platform Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorMaastricht University Medical Center

About this trial

The multicenter Cardiology Monitoring Platform registry (mCMP-registry) is a prospective observational registry including multi-omics (diagnostic) measurements performed as part of routine clinical care, bio-banking (optional), and yearly questionnaires (optional).

It's objective is to optimize (early) diagnosis and risk-stratification of (early) cardiovascular diseases, specifically cardiomyopathy phenotypes, arrhythmias, and coronary artery disease, and to create a better understanding of underlying pathophysiological processes.

Eligibility criteria

Qualifiers

Referred to the cardiology or genetic department for heart failure like symptoms (as stated in the ESC 2016 Guidelines(3)) or for cardiac/cardiogenetic screening;

Age ≥16 years.

Disqualifiers

Unwillingness to participate or unable to give written informed consent (e.g. due to language barriers or severe intellectual disability).

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

40,000 Participants
are grouped into 1 trial group

Sponsors and collaborators

Maastricht University Medical Center

Lead sponsor

Zuyderland Medical Centre

Collaborator